Pediatric patients are different from adult patients with respect to airway anatomy and
breathing patterns. They are also incapable of following commands and often reject …

Respiratory Syncytial Virus (RSV) is a common virus that infects children and adults;
however, children younger than two years of age tend to develop more serious respiratory …

Background Current clinical practice during high-flow nasal therapy (HFNT) involves
utilization of a nasal cannula to provide humidification, with a facemask placed over the …

Bronchiolitis is a common disorder in young children that often results in hospitalisation.
Except for a possible effect of nebulised hypertonic saline (sodium chloride), no evidence …

Infants have low tidal volume, vital capacity, and functional residual capacity, and short
respiratory cycles (low I: E ratio), which result in a low residence time for aerosol particles …

BACKGROUND: High-flow nasal cannula (HFNC) is increasingly used to provide respiratory
support in infants with bronchiolitis. The delivery of aerosol therapy through a jet nebulizer is …

Infants and children constitute a patient group that has unique requirements in pulmonary
drug delivery. Since their lungs develop continuously until they reach adulthood, the airways …

Background: Small volume nebulisers (SVNs) with masks commonly provide aerosol
therapy for infants with lung diseases. However, infants and toddlers are often disturbed by …

Background: An infant air-jet dry powder inhaler (DPI) platform has recently been developed
that in combination with highly dispersible spray-dried powder formulations can achieve …

Infants (0–1 years of age) and young children (1–3 years of age) are a unique
subpopulation with regard to inhaled therapies. There are various anatomic, physiological …